Document is current
Any future updates will be listed below
-
Authors
Shen, Li
Jhund, Pardeep S.
Anand, Inder S.
Carson, Peter E.
Desai, Akshay S.
Granger, Christopher B.
Køber, Lars
Komajda, Michel
McKelvie, Robert S.
Pfeffer, Marc A.
Solomon, Scott D.
Swedberg, Karl
Zile, Michael R.
McMurray, John J. V.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00095238 at ClinicalTrials.govnct00094302 at ClinicalTrials.govDocuments that mention this clinical trial
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
https://doi.org/10.1007/s00392-020-01786-8
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
https://doi.org/10.1161/circulationaha.122.063642
nct00634712 at ClinicalTrials.govDocuments that mention this clinical trial
Changes in frailty based on minimally important difference and the impact of spironolactone on frailty in heart failure with preserved ejection fraction: insights from the TOPCAT trial
https://doi.org/10.1136/openhrt-2025-003487
Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
https://doi.org/10.1016/j.ahj.2011.09.007
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
https://doi.org/10.1007/s00392-020-01786-8
Association of serum potassium time in target range with cardiovascular outcomes in patients with HFpEF
https://doi.org/10.1136/openhrt-2025-003439
Medical therapy for chronic heart failure
https://doi.org/10.1016/s0140-6736(11)61038-6
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
https://doi.org/10.1161/circulationaha.122.063642
Influence of depression trajectories in heart failure patients with preserved ejection fractions: a secondary analysis of adverse outcomes in the TOPCAT trial
https://doi.org/10.1136/heartjnl-2024-324505
Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial
https://doi.org/10.1055/a-1932-8854
Documents that mention this clinical trial
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
https://doi.org/10.1007/s00392-020-01786-8
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
https://doi.org/10.1161/circulationaha.122.063642
-
Funding
Funding for this research was provided by:
University of Glasgow
- License Information
-
More Information
Article History
Received: 25 August 2020
Accepted: 24 November 2020
First Online: 10 December 2020
Compliance with ethical standards
:
: No author has a disclosure relevant to the subject of this manuscript.
